Monitoring intravenous immunoglobulin dosing regimens in chronic inflammatory demyelinating polyneuropathy: search for a biomarker.
Main Authors: | Wakerley, B, Yuki, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
by: Anthony Khoo, et al.
Published: (2019-02-01) -
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective
by: Dario Cocito, et al.
Published: (2023-11-01) -
Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Ludger Feyen, et al.
Published: (2023-03-01) -
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
by: Juliane Klehmet, et al.
Published: (2023-05-01) -
Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)